RAB28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.620800E-01
Normal-vs-Stage2
6.735000E-01
Normal-vs-Stage3
1.403230E-01
Normal-vs-Stage4
9.836200E-01
Stage1-vs-Stage2
5.836000E-01
Stage1-vs-Stage3
5.522000E-02
Stage1-vs-Stage4
9.471800E-01
Stage2-vs-Stage3
1.128380E-01
Stage2-vs-Stage4
6.106200E-01
Stage3-vs-Stage4
1.603820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.965400E-01
Normal-vs-AfricanAmerican
7.873600E-01
Normal-vs-Asian
4.550600E-01
Caucasian-vs-AfricanAmerican
9.519600E-01
Caucasian-vs-Asian
3.555200E-01
AfricanAmerican-vs-Asian
4.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.587600E-01
Normal-vs-Female
8.298200E-01
Male-vs-Female
7.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.746600E-01
Normal-vs-Age(41-60Yrs)
8.636200E-01
Normal-vs-Age(61-80Yrs)
6.454200E-01
Normal-vs-Age(81-100Yrs)
4.837200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.345000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.852600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.006800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.628000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.767790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.007800E-01
Normal-vs-Daily Drinker
6.303800E-01
Normal-vs-Weekly Drinker
7.892400E-01
Normal-vs-Occasional Drinker
8.578200E-01
Normal-vs-Social Drinker
9.821600E-01
Non Drinker-vs-Daily Drinker
3.209600E-01
Non Drinker-vs-Weekly Drinker
3.073200E-01
Non Drinker-vs-Occasional Drinker
2.950300E-02
Non Drinker-vs-Social Drinker
9.430500E-02
Daily Drinker-vs-Weekly Drinker
8.334400E-01
Daily Drinker-vs-Occasional Drinker
2.338200E-01
Daily Drinker-vs-Social Drinker
4.249600E-01
Weekly Drinker-vs-Occasional Drinker
4.472000E-01
Weekly Drinker-vs-Social Drinker
6.428600E-01
Occasional Drinker-vs-Social Drinker
8.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.789800E-01
Normal-vs-Grade 2
9.738200E-01
Normal-vs-Grade 3
9.746000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.334600E-01
Grade 1-vs-Grade 3
9.482000E-01
Grade 1-vs-Grade 4
9.789800E-01
Grade 2-vs-Grade 3
9.828000E-01
Grade 2-vs-Grade 4
9.738200E-01
Grade 3-vs-Grade 4
9.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.873400E-01
Normal-vs-NonDiabetic
8.420800E-01
Diabetic-vs-NonDiabetic
8.172400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.854600E-01
Normal-vs-NoPancreatitis
7.498000E-01
Pancreatitis-vs-NoPancreatitis
3.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.786200E-01
Normal-vs-N1
6.873600E-01
N0-vs-N1
2.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.673400E-01
Normal-vs-TP53-NonMutant
7.105000E-01
TP53-Mutant-vs-TP53-NonMutant
9.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
